FactSet held its Investor Day to present its strategy and financial outlook through fiscal 2029, aiming for 6% annual revenue growth and a 36% adjusted operating margin by 2029. The company reaffirmed its 2027 guidance, targeting revenues of $2.6-$2.625 billion, a GAAP operating margin of 31%-32%, and adjusted diluted EPS between $19.25 and $19.65. FactSet emphasizes its focus on AI-driven financial intelligence to enhance client offerings and long-term shareholder value. The event included presentations from key executives and will be available online for a year.
FactSet's Investor Day 2026 provides context for readers interested in financial technology developments. For readers following the Technology sector, here is Pluang's market snapshot as of Nov 10, 2026 18:12 WIB: out of 150 priced US Technology stocks tradable on Pluang, 51 rose and 89 fell. Notable movers include WIX at USD 66.74 with a 1-day change of -4.32%, TTWO at USD 215.47 up 3.89% with a typical hold time of 115 days and a Pluang order activity of 45% Sell / 55% Buy, and QUBT at USD 6.63 down 3.35% with 98% Sell orders. The most notable figure is TTWO's 3.89% gain.
The 2026 Verizon Data Breach Investigations Report links 61% of manufacturing breaches to third parties and 81% to internal data compromise. Manufacturers adopting Microsoft 365 Copilot should carefully manage which engineering and supplier files emp...
Soleo Health has been selected as a specialty pharmacy partner for Pasatru™ (garetosmab-grts), Regeneron's FDA-approved treatment for adults with fibrodysplasia ossificans progressiva (FOP), an ultra-rare genetic disorder. Pasatru™ is the first treat...
PsiThera raised $25 million in financing led by new investors AbbVie Ventures and Lumination Capital, alongside existing backers. The funds will support development of its oral small molecule TNFα inhibitor and advance its oral TL1A inhibitors into l...
Opus Genetics announced its Q3 2026 financial results and significant progress in its gene therapy programs for inherited retinal diseases. Key milestones include completion of dosing in OPGx-BEST1 Cohort 2 with data expected in Q1 2027, full enrollm...
Iveco Group is exhibiting its latest products, including new light and heavy-duty vehicles powered by FPT engines, at Fenatran 2026 in São Paulo, highlighting its strong industrial and commercial presence in Latin America. The event marks the regiona...
